DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Dai C, Zhou F, Shao JH, Wu LQ, Yu X, Yin XB.
Bleeding risk in cancer patients treated with sorafenib: a meta-analysis of randomized controlled trials.
J Cancer Res Ther 2018;
14 (Supplement): S948-S956
We do not assume any responsibility for the contents of the web pages of other providers.